Health & Medical for Sale in Illinois

A rare opportunity to acquire a fully licensed, multi-modality diagnostic imaging center with a long-standing reputation and proven revenue history. Located in the prestigious suburb of Oak Brook, IL, this center has been serving the Chicago healthcare market since 1985, with no adverse actions and positive net revenues. Ke Highlights: Location: Oak Brook, IL – Adjacent to the Joint Commission Established: 1985 Modalities: MRI, CT, PET, Mammography, Ultrasound, X-Ray, Bone Density & more Employees: 12+ experienced staff including radiologists, technologists, billing, and marketing teams Client

Presenting an exceptional opportunity to acquire an established non-medical home care franchise. This business specializes in private pay, Medicaid, VA, and long-term care insurance services, catering to a rapidly expanding market in the health, medical, fitness, and beauty sector. With an asking price of just $12,500, this franchise is a scalable venture with nationwide potential, ensuring a promising return on investment. ZERO FRANCHISE FEE!! The franchise offers a turnkey business model, with franchisees receiving full onboarding, lead generation assistance, and operations coaching. The

Home Health for Sale in Illinois Est. in 2006 3 Licenses: Home Health, Caregiver, and Private Duty Nursing Turnkey! - Potential for Much More Growth Current Census: 25 No ADRs/Audits - IDPH Certified Medicare and Medicaid Certified Accepted Insurances: Aetna, Humana, Meridian, Optum VA, & UHC Counties Covered: McHenry, Lake, Kane, DuPage, Cook, Kendall, & Will Reduced Asking Price: $649K Reference Number: 7972838314 Cash equivalent to purchase price set aside to invest from currently available funds required – Healthcare-specific industry experience required –

The Company is a clinical-stage oncology company with a platform that combines biospectral impedance and AI/ML for point-of-care cancer detection. The lead product delivers rapid, in-procedure assessment of surgical margins—identifying the presence and location of cancer within minutes. Initial commercialization targets skin cancer, where the lead product can shorten procedures, spare healthy tissue, improve surgeon economics, and enhance outcomes. The Company has also built a compelling breast cancer dataset and plans to deploy the lead product to help dramatically reduce the ~20–25% re-surge